Skip to main content
Canadian Respiratory Journal logoLink to Canadian Respiratory Journal
. 2008 Jul-Aug;15(5):249–254. doi: 10.1155/2008/369162

Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: Insights from a multicentre study

Graeme M Rocker 1,, Peter M Dodek 2, Daren K Heyland 3; for the Canadian Researchers at the End of Life Network
PMCID: PMC2679546  PMID: 18716686

Abstract

BACKGROUND:

Understanding patients’ needs and perspectives is fundamental to improving end-of-life (EOL) care. However, little is known of what quality care means to patients who have advanced lung disease.

OBJECTIVES:

To describe ratings of importance and satisfaction with elements of EOL care, informational needs, decision-making preferences, obstacles to a preferred location of death, clinical outcomes, and health care use before and during an index hospital admission for patients who have advanced chronic obstructive pulmonary disease (COPD).

METHODS:

A questionnaire with regard to quality EOL care was administered to patients older than 55 years of age who had advanced medical disease in five Canadian teaching hospitals.

RESULTS:

For 118 hospitalized patients who had advanced COPD, the following items were rated as extremely important for EOL care: not being kept alive on life support when there is little hope for meaningful recovery (54.9% of respondents), symptom relief (46.6%), provision of care and health services after discharge (40.0%), trust and confidence in physicians (39.7%), and not being a burden on caregivers (39.6%). Compared with patients who had metastatic cancer, patients with COPD had lower (P<0.05) satisfaction with care, interest in information about prognosis, cardiopulmonary resuscitation or mechanical ventilation, and referral rates to palliative care, whereas use of acute care services was higher (P<0.05) for patients who had advanced COPD.

CONCLUSION:

Canadian patients who have advanced COPD identify several priorities for improving care. Avoidance of prolonged or unwanted life support requires more effective communication, decision making and goal setting. Patients also deserve better symptom control and postdischarge strategies to minimize perceived burdens on caregivers, emergency room visits and hospital admissions.

Keywords: Chronic obstructive pulmonary disease, Decision making, End-of-life care


Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in Canada. Because it is one of the most common chronic diseases, COPD is a major cause of morbidity and mortality. By 2018, it will cause more than 20,000 deaths in Canada per year and become the third leading cause of death in the world (1,2). Of the six leading causes of death in the United States, COPD is the only one that has had a steadily increasing incidence over the past 30 years (3).

The final years before death for patients who have advanced COPD are characterized by progressive functional decline, poor quality of life and increasing dependency on informal caregivers. Patients who survive a hospitalization after an acute exacerbation of COPD (mortality of index admission is usually between 2.5% and 12% [4,5]) often experience shortness of breath for the rest of their lives (4). Relative to patients who have cancer, those who have COPD spend increasing lengths of time in the hospital because their disease progresses (6), have a higher burden of symptoms (7,8), and are more likely to have poorly controlled (9) and incapacitating (1014) dyspnea as the predominant symptom.

Understanding patients’ needs and perspectives at the end of life (EOL) is fundamental to making improvements in provision of care. We have reported elsewhere the key elements of quality of EOL care identified by 434 seriously ill hospitalized patients at high risk of six-month mortality in Canada (15). We asked these patients (and their care-givers, if available) to identify aspects of EOL care most important to them, and we also asked patients and caregivers how satisfied they were with those aspects of care (15,16). For seriously ill patients and their family members, the most important elements of quality EOL care were trust in the treating physician, avoidance of unnecessary life support, effective communication, continuity of care, and life completion. Variation in the perception of what matters the most indicated the need for customized or individualized approaches to providing EOL care (15,16).

In the context of the need for better EOL care, and in response to recent calls for greater advocacy for patients who have COPD (17,18) and for involvement from palliative care providers in the management of advanced COPD (17,18), we have reviewed our COPD-specific data from the study described above (15,16). For the 118 patients who had advanced COPD, we describe herein their ratings of importance and satisfaction with elements of EOL care, their informational needs and decision-making preferences, the obstacles (if any) to a preferred location of death, their clinical outcomes, and their health care use before and during an index hospital admission. To frame these findings, we draw comparisons with patients who had cancer from our previously published cohort. Illuminating these issues should enrich our nascent understanding of the needs and preferences of Canadian patients who have advanced COPD, and inform innovative approaches in Canada to improving care during the advanced stages of an incurable disease.

METHODS

A survey was conducted in five tertiary referral teaching hospitals in the cities of Vancouver (British Columbia), Halifax (Nova Scotia), Toronto (Ontario), Kingston (Ontario) and Edmonton (Alberta) between November 2001 and June 2003. The methodological details and aggregated study results have been published previously (15,16). A total of 434 patients participated in the overall study. For the present substudy, 118 patients aged 55 years or older who were at high risk (30% to 50%) of COPD mortality at six months – as defined by at least two of the following: baseline arterial partial pressure of CO2 greater than 45 mmHg, documentation of a previous episode of acute respiratory failure within the past 12 months or of cor pulmonale, or forced expiratory volume in 1 s of 0.75 L or less – were included. (The definition of severe COPD was the same as that used in the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments [SUPPORT] study [4].) The present substudy also included the 166 patients who had cancer as defined by metastatic disease or grade 4 lymphoma. Patients who had probable communication difficulties, including those who did not understand English or who had cognitive barriers, were excluded. Before participation, all study subjects provided written informed consent. The study was approved by the institutional research ethics boards of the participating hospitals.

The processes for questionnaire development, patient screening, enrolment and the questions themselves were described previously (15,16). Briefly, the questionnaire was composed of 28 items that addressed five domains: medical and nursing care, communication and decision making, social relationships and support, meaningful existence, and advance care planning. A research coordinator at each site administered the questionnaire in person to eligible patients. Response options were used to assess each item using a five-point ordinal scale for degree of importance (1, not at all important; 2, somewhat important; 3, important; 4, very important; and 5, extremely important) and satisfaction with care (1, not at all satisfied; 2, not very satisfied; 3, somewhat satisfied; 4, very satisfied; and 5, completely satisfied). Patients were asked to indicate their preferences for decision making (leave decision up to doctor, doctor decides but considers my wishes, doctor and I share decision, I decide but consider the doctors’ wishes, I make decision myself). Regarding informational needs for a particular intervention (eg, cardiopulmonary resuscitation [CPR]), patients were asked to indicate whether they would want a lot of information, some information or would not want any information.

Patients rated their preferences for current levels of care from 0 to 10 on a score card, in which 0 meant the focus of care was primarily concentrated on treatments to extend life as much as possible even if that meant having more pain and discomfort, to 10, a plan of care that focuses only on relieving pain and discomfort as much as possible, even if that meant not living as long. From a chart review of responding patients, data concerning documentation of EOL discussions (whether EOL care orders were written [eg, CPR or the presence or absence of orders regarding level of care]), and health care use in the 12 months before the index admission (eg, emergency room visits, hospital admissions) and during the index admission (eg, intensive care unit [ICU] admission, ICU lengths of stay, intermediate care unit admission, palliative care referral and/or admission, and palliative care length of stay) were recorded. Finally, the six-month mortality rate was determined for enrolled patients by contact with patients, family members or family physicians.

Statistical analysis

Summary statistics for continuous and categorical data are provided. For comparisons between patients who had advanced COPD versus patients who had cancer, we used t tests or Pearson’s χ2 analysis when appropriate. In comparisons of patients’ ratings of importance or satisfaction, the P value relates to the difference in proportions between patients who had COPD and patients who had cancer, rating an element as extremely important or completely satisfied in relation to the other categories of importance or satisfaction.

RESULTS

The mean (± SD) age of the 118 patients who had COPD in the present study was 73±7.8 years, and 34% lived alone. In addition, these patients were more likely to be older as well as widowed (Table 1), and less likely to have completed postsecondary education (data not shown). Compared with cancer patients, patients who had COPD reported an overall lower quality of life. Additional demographic characteristics are presented in Table 1.

TABLE 1.

Demographics of study subjects

Characteristic COPD, n=118 Cancer, n=166 P
Age, years, mean ± SD 73.27±7.84 70.25±8.57 <0.01
Sex, % 0.94
  Female 52.5 45.8
  Male 45.8 52.4
  Missing 1.7 1.8
Race, % 0.13
  Caucasian 98.3 91.0
  Other 1.7 9.0
Marital status, % 0.03
  Married or common law 47.5 57.2
  Widowed 36.4 21.1
  Separated or divorced 9.3 15.1
  Never married 2.5 2.4
  Unknown 4.2 4.2
Living arrangements, % 0.14
  With spouse or partner 45.8 57.2
  Alone 33.9 28.9
  With other family 16.1 8.4
  Nursing home 1.7 0.6
  Chronic care facility 0.8 1.8
  Unknown 1.7 3.0
Location of home, % 0.16
  Rural 21.4 28.8
  Urban 78.6 71.6
Overall quality of life, % 0.05
  Excellent 1.7 4.2
  Very good 4.2 12.7
  Good 16.9 15.7
  Fair 39.8 27.7
  Poor 33.1 30.7
  Unknown 4.2 9.0

COPD Chronic obstructive pulmonary disease

The elements of EOL care that were most important to patients who had COPD were the following: ‘not to be kept alive on life support when there is little hope for a meaningful recovery’ (the only item rated extremely important by more than 50% of patients in both groups); ‘to have relief of symptoms, ie, pain, shortness of breath, nausea, etc’; and ‘to have an adequate plan of care and health services available to look after you at home upon discharge from hospital’. These three elements did not differ in importance from the ratings by patients who had cancer (Table 2), although two of the ten most important factors for patients who had COPD were significantly more important for cancer patients than COPD patients: ‘trust and confidence in the doctors looking after you’ (65.2% versus 39.7%, respectively) and ‘complete things and prepare for life’s end’ (52.8 % versus 30.7%, respectively).

TABLE 2.

Top 10 elements of end-of-life (EOL) care that patients with advanced chronic obstructive pulmonary disease (COPD) considered extremely important

Element COPD (n=118), n (%) Cancer (n=166)
P
n (%) Rank
1. Not to be kept alive on life support when there is little hope for a meaningful recovery 62 (54.9) 88 (58.3) 2 0.58
2. To have relief of symptoms, ie, pain, shortnesss of breath, nausea, etc 55 (46.6) 60 (37.0) 12 0.11
3. To have an adequate plan of care and health services available to look after you at home upon discharge from hospital 46 (40.0) 73 (44.0) 6 0.15
4. To have trust and confidence in the doctors looking after you 46 (39.7) 105 (65.2) 1 <0.01
5. That you not be a physical or emotional burden on your family 44 (39.6) 70 (46.7) 5 0.27
6. To receive respectful and compassionate care from health care providers 39 (33.1) 59 (36.6) 13 0.53
7. To complete things and prepare for life’s end (life review, resolving conflicts, saying goodbye) 35 (30.7) 76 (52.8) 3 <0.01
8. To have an opportunity to strengthen relationships with people that are important to you 33 (28.9) 60 (39.7) 9 0.07
9. To be treated as an individual with unique needs, values and preferences and not just a disease 29 (25.4) 46 (28.8) 20 0.55
10. To have information regarding your medical history and needs be readily available to doctors treating you upon admission to hospital 28 (25.2) 49 (33.1) 16 0.17

Data presented are elements of EOL care that patients who had advanced COPD rated as extremely important. Ranking is based on the proportion of patients within the COPD cohort rating each element of EOL care as extremely important. By comparison, data from patients who had cancer according to how they rated the same elements of EOL care (in terms of importance) and our ranking of those elements are presented. The P value relates to differences in proportions between patients who had COPD and patients who had cancer, in rating each element as extremely important

Patients who had COPD were most satisfied with the following elements: ‘to receive adequate information about your disease including the risks and benefits of treatment options’, ‘to have trust and confidence in the doctors looking after you’, and ‘to know which doctor is the main doctor in charge of your care’. However, less than one-third of patients were completely satisfied with any of these top-ranking elements of satisfaction. Of the 10 top-rated items of importance in EOL care for patients who had COPD, only three appeared in the top ten ratings of satisfaction (‘trust and confidence in the doctors looking after you’, ‘to have an opportunity to strengthen relationships’ and ‘to complete things and prepare for life’s end’; Table 3). For nine of the 10 satisfaction elements, patients who had COPD were less satisfied with current care than cancer patients. For six of these nine elements, the proportion of COPD patients who were completely satisfied was significantly lower than the comparable proportion of cancer patients (Table 3).

TABLE 3.

Satisfaction with current care

Element COPD (n=118), n (%)* Cancer (n=166), n (%)* P
To receive adequate information about your disease including the risks and benefits of treatment options 39 (33.9) 31 (19.6) 0.01
To have trust and confidence in the doctors looking after you 28 (24.1) 58 (36.0) 0.04
To know which doctor is the main doctor in charge of your care 25 (21.9) 58 (36.0) 0.01
That the doctor discuss concerns relating to your illness and care with your family present 22 (20.8) 48 (34.0) 0.02
That your illness not create financial problems for your family 21 (19.8) 40 (29.9) 0.08
To have trust and confidence in the nurses looking after you 23 (19.7) 42 (26.4) 0.19
That information about your disease be communicated to you by your doctor in an honest manner 22 (19.6) 56 (36.1) <0.01
To have your spiritual or religious needs met 17 (19.1) 33 (28.4) 0.12
To have an opportunity to strengthen relationships with people that are important to you 19 (17.4) 48 (32.9) <0.01
To complete things and prepare for life’s end (life review, resolving conflicts, saying goodbye) 18 (16.2) 46 (30.2) <0.01
*

Per cent is the proportion of total number of responses to a specific question. Data presented are elements of end-of-life (EOL) care that patients who had advanced chronic obstructive pulmonary disease (COPD) rated as completely satisfied. Ranking (from 1 to10) is based on the proportion of patients within the COPD cohort rating each element of EOL care as completely satisfied. By comparison, data from patients who had cancer according to how they rated the same elements of EOL care (in terms of satisfaction) are presented. The P value relates to differences in proportions between patients who had COPD and patients who had cancer, in rating each element as completely satisfied

Patients who had COPD or cancer had similar views on the relevance of EOL issues on models of decision making (autonomous, shared or doctor-driven) and on preferred location of death (home, hospital or does not matter; data not shown). Regarding informational needs, fewer patients who had COPD versus those who had cancer wanted to know about their prognosis and disease progression (29.7% versus 49.5%, respectively; Table 4), or about CPR, while a higher proportion of COPD patients wanted no information at all about CPR (27% of COPD patients versus 21% of cancer patients, data not shown). Similar proportions of both patient groups (31.9% of COPD patients, 38.5% of cancer patients) believed it was very important to know about ICUs but a lower proportion of patients who had COPD rated it extremely important to know about mechanical ventilation (29% of COPD patients versus 45% of cancer patients). Fewer patients who had COPD, versus patients who had cancer, recalled any discussion about how long they might live (8.7% versus 26.5%, respectively). A higher proportion of patients who had COPD versus those who had cancer (85% versus 68%, respectively) would call 911 as their plan in an emergency. More than 55% of patients in both groups indicated that burdens on their informal caregivers would prevent them from dying at home if that were their choice, and more than 45% in both groups indicated that a lack of adequate services would prevent a home death (data not shown). Patients who had COPD chose a level of care that was more focused on prolongation of life than patients who had cancer (Table 4).

TABLE 4.

Processes of care and resource use

COPD (n=118) Cancer (n=166) P
Preference for level of care, mean ± SD 4.85±3.14 5.93±3.33 0.01
Plan of care in place for emergency, % 65.3 53.1 0.06
In emergency, % <0.01
  Call 911 85.4 68.0
  Home visit 5.8 11.7
Had discussion – how long to live, % 8.7 26.5 <0.01
Have understanding of how long to live, % 0.09
  More than one year 66.7 20.0
  Approximately one year 0.0 2.9
  Approximately six months 11.1 14.3
  Less than six months 22.2 48.6
  Less than one month 0.0 14.3
Want to know progression and prognosis, % 29.7 49.5 <0.01
Currently facing EOL issues, % 63.4 58.1 0.39
EOL discussions and referrals, %
  Have had EOL discussion 48.3 55.1 0.31
  EOL order written 53.9 61.9 0.23
  Palliative care consult (yes) 31.1 59.2 <0.01
  Homecare consult (yes) 39.3 42.9 0.59
Resource use, mean ± SD
  Previous 12 months
    Emergency room visits 5.33±17.76 1.60±1.81 0.05
    Hospital admissions 1.96±1.23 1.88±1.35 0.69
  Index admission
    Hospital length of stay, days 42.72±52.87 35.40±39.66 0.24
    Intensive care unit days 1.24±3.87 0.16±0.83 <0.01
    Intermediate care days 1.75±8.93 0.30±1.14 0.08
    Palliative care unit days 0.10±0.82 2.34±9.93 <0.01

Ranking from 0 to 10, in which 0 means extending life as much as possible and 10 means relieving discomfort as much as possible. Data on obstacles to a preferred location of death, planning for emergencies, needs for information about prognosis, discussions about end-of-life (EOL) care, and relative use of acute care services both before and during the index admission are presented. COPD Chronic obstructive pulmonary disease

EOL discussions occurred and EOL care orders were documented in the charts for 54% of patients who had advanced COPD and for 62% of those who had cancer. Patients who had COPD had more emergency room visits in the previous 12 months, spent more time in an ICU during the index admission and were less likely to be referred to palliative care services (Table 4). Six-month mortality was higher for patients who had cancer than for patients who had COPD (75.9% versus 37.3%, respectively).

DISCUSSION

In the present multicentre Canadian study, the elements of EOL care that were most important to patients who had COPD included the following: not to be kept alive on life support when there is little hope for a meaningful recovery, to have relief of symptoms, and to have an adequate plan of care in place beyond hospital discharge. Patients who had advanced COPD were, in general, less satisfied with their care than patients who had cancer. Imbalances in ratings of importance between elements of EOL care and satisfaction with care highlight opportunities for improvement in EOL care for patients who have COPD.

Patients who have COPD seem less inclined to discuss their prognoses. Despite the finding that ‘not being kept alive on a machine when there was no meaningful chance of recovery’ was an item rated as extremely important by more than 50% of both groups of patients, significantly fewer patients who had advanced COPD (versus cancer) were prepared to discuss or wanted to know about mechanical ventilation. Curtis et al (19,20) have also reported that a significant proportion of patients who have advanced lung disease would decline opportunities to discuss EOL issues. In contrast, in previous studies (21,22) that included COPD patients from the United States and the United Kingdom, nearly all patients believed that these issues should be discussed. These conflicting results point to a need to target our educational strategies for our COPD patients on an individual basis, something patients themselves would likely welcome based on their rating of the importance of respect for their values and preferences (Table 2).

A health care system that provides timely, comprehensive and compassionate care at the EOL will do so according to patient needs and symptom burden, and in a setting of their choice, rather than on the basis of a primary diagnosis or disease. Patients who have COPD are not strong self-advocates, and as yet, health care systems on which they increasingly depend have also failed to advocate effectively for their needs (17). It was therefore disappointing, but not surprising, that 85% of patients who had COPD would feel the need to call 911 as their plan in an emergency, perhaps reflecting less well developed or accessible home care supports, or insufficient advanced directives for this patient group. The lack of home support might explain our finding that perceived burdens on informal caregivers (for 63% of respondents) and lack of adequate services (for 45%) would prevent a home death if that were their preference. With recognition of inadequate palliation of dyspnea as COPD progresses, and in the context of calls from professional societies for greater involvement from palliative care services (23), we were encouraged that more than 30% of patients who had advanced COPD were referred to palliative care services during their index admission. Nevertheless, we suspect that other patients who had advanced COPD in the study might have benefited from a high quality symptom-focused interventional strategy and access to palliative care that cancer patients already received (8,2426).

Patients who had COPD had greater use of acute care settings, including admissions to an ICU (Table 4), and fewer referral rates to palliative care, confirming previous work in the United States and the United Kingdom (4,6,7,9). In our cohort of patients predicted to have a six-month mortality (approximately 50%), fewer patients who had COPD recalled any discussion about how long they might live. Nevertheless, it is encouraging that on the wards of the participating hospitals EOL discussions occurred and EOL care orders were documented for more than 50% of all patients. What is not clear is whether such discussions in the remaining patients were attempted but declined by the patients or simply not addressed by their physicians.

Limitations of the present substudy may include our method of ranking items, which we did on the basis of the proportions of patients indicating an item as extremely important. The predominantly Caucasian sample drawn from tertiary care hospitals might limit the generalizability of our findings to other settings within Canada. We recognize that satisfaction with care does not equate to quality of care. We did not ask patients to identify which specific symptom was most important to control. Nevertheless, because dyspnea is almost universal in advanced COPD and a major contributor to poor quality of life (13,27), we believe that it is reasonable to assume that symptoms include dyspnea. We did not measure prevalence of anxiety or depression, which are common occurrences in COPD (11,28) that may influence patient choices and perspectives (29), or be a cause of some emergency room visits. We recognize that more qualitative studies are needed to further explore what COPD patients consider a ‘meaningful recovery’ after ICU admission. Furthermore, our study design did not allow us to record resource use after the index admission.

CONCLUSIONS AND RECOMMENDATIONS

For patients who had advanced COPD in our study, the most important element of EOL care was ‘not to be kept alive on life support when there is little hope for a meaningful recovery’. This finding contrasts strikingly with our other findings in that such patients at high risk of six-month mortality were less likely than cancer patients to have had (or wanted) a discussion about prognosis, had rated it less important to ‘complete things and prepare for life’s end’, were less likely to want to know about mechanical ventilation, and yet were more likely to call 911 and be admitted to an emergency room or ICU. These findings speak to our need to communicate more often and more effectively to set more realistic goals of care for patients with advanced COPD. We need to focus on strategies to improve symptom control (30) and effective care after hospital discharge. We need innovative approaches to achieve these aims (31) in acute care and in community settings. To set realistic goals, we need to engage patients in meaningful discussions about an uncertain prognosis, while maintaining hope about likely future events. To achieve better symptom control (30) and to optimize life remaining, we can seek help from colleagues in palliative care. We should reconsider our conventional approaches so that the management of symptoms in advanced COPD receives, at a minimum, similar attention to palliative care of key cancer-related symptoms. In addition, to minimize patient fears of being a burden to their informal care-givers, as well as to reduce emergency room visits and hospital admissions, we should be developing adequate community-based resources on which patients and informal caregivers living with COPD or any advanced disease can depend on (32), even in a crisis (33).

Acknowledgments

The authors would like to thank Diane Allan, Research Associate at the Centre on Aging, University of Victoria, Victoria, British Columbia, for her assistance with data analysis.

We would also like to thank all the study personnel and site investigators (see reference 16 for full details) who participated in this study at the participating hospitals: Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia (800 beds); Kingston General Hospital, Kingston, Ontario (400 beds); Toronto General Hospital, Toronto, Ontario (471 beds); St Paul’s Hospital, Vancouver, British Columbia (400 beds); Royal Alexandra Hospital, Edmonton, Alberta (520 beds).

Footnotes

FUNDING: This study was supported by the National Health Research and Development Program of Canada.

REFERENCES

  • 1.Lacasse Y, Brooks D, Goldstein RS. Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest. 1999;116:306–13. doi: 10.1378/chest.116.2.306. [DOI] [PubMed] [Google Scholar]
  • 2.Respiratory Disease in Canada Ottawa: Canadian Institute for Health Information, Canadian Lung Association, Health Canada, Statistics Canada; 2001. <http://www.phac-aspc.gc.ca/publicat/rdc-mrc01/index.html> (Version current at June 2, 2008). [Google Scholar]
  • 3.Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294:1255–9. doi: 10.1001/jama.294.10.1255. [DOI] [PubMed] [Google Scholar]
  • 4.Lynn J, Ely EW, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2000;48(5 Suppl):S91–100. doi: 10.1111/j.1532-5415.2000.tb03147.x. [DOI] [PubMed] [Google Scholar]
  • 5.Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163:1180–6. doi: 10.1001/archinte.163.10.1180. [DOI] [PubMed] [Google Scholar]
  • 6.Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006;166:326–31. doi: 10.1001/archinte.166.3.326. [DOI] [PubMed] [Google Scholar]
  • 7.Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55:1000–6. doi: 10.1136/thorax.55.12.1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31:58–69. doi: 10.1016/j.jpainsymman.2005.06.007. [DOI] [PubMed] [Google Scholar]
  • 9.Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: Insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc. 2000;48(5 Suppl):S146–53. doi: 10.1111/j.1532-5415.2000.tb03124.x. [DOI] [PubMed] [Google Scholar]
  • 10.Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001;15:287–95. doi: 10.1191/026921601678320278. [DOI] [PubMed] [Google Scholar]
  • 11.Bailey PH. The dyspnea-anxiety-dyspnea cycle – COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qual Health Res. 2004;14:760–78. doi: 10.1177/1049732304265973. [DOI] [PubMed] [Google Scholar]
  • 12.Jones I, Kirby A, Ormiston P, et al. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam Pract. 2004;21:310–3. doi: 10.1093/fampra/cmh317. [DOI] [PubMed] [Google Scholar]
  • 13.Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med. 2005;19:485–91. doi: 10.1191/0269216305pm1056oa. [DOI] [PubMed] [Google Scholar]
  • 14.Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life of COPD: A qualitative study of symptoms and services. Respir Med. 2004;98:439–45. doi: 10.1016/j.rmed.2003.11.006. [DOI] [PubMed] [Google Scholar]
  • 15.Heyland DK, Dodek P, Rocker G, et al. What matters most in end-of-life care: Perceptions of seriously ill patients and their family members. CMAJ. 2006;174:627–33. doi: 10.1503/cmaj.050626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Heyland DK, Groll D, Rocker G, et al. End-of-life care in acute care hospitals in Canada: A quality finish? J Palliat Care. 2005;21:142–50. [PubMed] [Google Scholar]
  • 17.Partridge MR. Patients with COPD: Do we fail them from beginning to end? Thorax. 2003;58:373–5. doi: 10.1136/thorax.58.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Liao S, Arnold RM. Chronic obstructive pulmonary disease: Thinking outside the opioid box. J Palliat Med. 2007;10:781–2. doi: 10.1089/jpm.2007.9952. [DOI] [PubMed] [Google Scholar]
  • 19.Curtis JR, Engelberg RA, Wenrich MD, Au DH. Communication about palliative care for patients with chronic obstructive pulmonary disease. J Palliat Care. 2005;21:157–64. [PubMed] [Google Scholar]
  • 20.Curtis JR, Engelberg RA, Nielsen EL, Au DH, Patrick DL. Patient-physician communication about end-of-life care for patients with severe COPD. Eur Respir J. 2004;24:200–5. doi: 10.1183/09031936.04.00010104. [DOI] [PubMed] [Google Scholar]
  • 21.Gaber KA, Barnett M, Planchant Y, McGavin CR. Attitudes of 100 patients with chronic obstructive pulmonary disease to artificial ventilation and cardiopulmonary resuscitation. Palliat Med. 2004;18:626–9. doi: 10.1191/0269216304pm944oa. [DOI] [PubMed] [Google Scholar]
  • 22.Heffner JE, Fahy B, Hilling L, Barbieri C. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med. 1996;154:1735–40. doi: 10.1164/ajrccm.154.6.8970363. [DOI] [PubMed] [Google Scholar]
  • 23.O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2003. Can Respir J. 2003;10(Suppl A):11A–65A. doi: 10.1155/2003/567598. [DOI] [PubMed] [Google Scholar]
  • 24.Kite S, Jones K, Tookman A. Specialist palliative care and patients with noncancer diagnoses: The experience of a service. Palliat Med. 1999;13:477–84. doi: 10.1191/026921699670359259. [DOI] [PubMed] [Google Scholar]
  • 25.Luddington L, Cox S, Higginson I, Livesley B. The need for palliative care for patients with non-cancer diseases: A review of the evidence. Int J Palliat Nurs. 2001;7:221–6. doi: 10.12968/ijpn.2001.7.5.12635. [DOI] [PubMed] [Google Scholar]
  • 26.Grbich C, Maddocks I, Parker D, et al. Identification of patients with noncancer diseases for palliative care services. Palliat Support Care. 2005;3:5–14. doi: 10.1017/s1478951505050029. [DOI] [PubMed] [Google Scholar]
  • 27.Skilbeck J, Mott L, Page H, Smith D, Hjelmeland-Ahmedzai S, Clark D. Palliative care in chronic obstructive airways disease: A needs assessment. Palliat Med. 1998;12:245–54. doi: 10.1191/026921698677124622. [DOI] [PubMed] [Google Scholar]
  • 28.Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries. Respir Med. 2006;100:87–93. doi: 10.1016/j.rmed.2005.04.003. [DOI] [PubMed] [Google Scholar]
  • 29.Stapleton RD, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest. 2005;127:328–34. doi: 10.1378/chest.127.1.328. [DOI] [PubMed] [Google Scholar]
  • 30.Rocker GM, Sinuff T, Horton R, Hernandez P. Advanced chronic obstructive pulmonary disease: Innovative approaches to palliation. J Palliat Med. 2007;10:783–97. doi: 10.1089/jpm.2007.9951. [DOI] [PubMed] [Google Scholar]
  • 31.Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: A qualitative phase 1 study. Palliat Support Care. 2006;4:287–93. doi: 10.1017/s1478951506060366. [DOI] [PubMed] [Google Scholar]
  • 32.Intermediate care – Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline. Thorax. 2007;62:200–10. doi: 10.1136/thx.2006.064931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rocker G. Defining moments: End-of-life care in the back of a truck. CMAJ. 2007;176:1614–5. [Google Scholar]

Articles from Canadian Respiratory Journal : Journal of the Canadian Thoracic Society are provided here courtesy of Wiley

RESOURCES